Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Raju Prasad currently holds 41,667 shares of CRISPR Therapeutics AG (CRSP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Raju Prasad has been a net seller of CRSP stock. They have purchased $0 and sold $2.9M worth of shares.
Raju Prasad's most recent insider trade was on Jan 22, 2026, when they sold 34,972 shares at $0.00 per share.
Raju Prasad serves as Executive at CRISPR Therapeutics AG (CRSP). They have executed 13 insider transactions totaling $2.9M over their tenure at the company.
Raju Prasad holds the position of Executive at CRISPR Therapeutics AG, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Raju Prasad has shown a selling trading pattern, with $0 in total purchases and $2.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Raju Prasad was on Jan 22, 2026, when they sold $2.1M worth of CRSP shares. This transaction involved 34,972 shares at $60.19 per share.
Raju Prasad currently owns 41,667 shares of CRISPR Therapeutics AG (CRSP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Raju Prasad's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Raju Prasad has 13 Form 4 filings on record as an insider at CRISPR Therapeutics AG.
Set alerts for Raju Prasad and 40,000+ other insiders.